Austria: The Current Status of Maintenance Treatment in Schizophrenia
Psychiatric hospitals in Austria have about 10000 beds for acute and chronic patients. We estimate that schizophrenic patients are responsible for about 20% of all acute hospital admissions, while the percentage of schizophrenics in long-stay units probably exceeds 30%. Twenty-nine neuroleptics of the various chemical classes are currently registered and marketed in Austria. Four of these (haloperidol, fluphenazine, flupenthixol and clopenthixol) are available in long-acting injectible depot preparations; one (penfluridol) is a long-acting oral antipsychotic.
KeywordsSchizophrenia Haloperidol Clozapine Decanoate Thioridazine
Unable to display preview. Download preview PDF.